1-167772479-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003953.6(MPZL1):c.463G>A(p.Val155Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000931 in 1,610,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_003953.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPZL1 | NM_003953.6 | c.463G>A | p.Val155Ile | missense_variant | Exon 3 of 6 | ENST00000359523.7 | NP_003944.1 | |
MPZL1 | NM_024569.5 | c.463G>A | p.Val155Ile | missense_variant | Exon 3 of 5 | NP_078845.3 | ||
MPZL1 | XM_047433610.1 | c.91G>A | p.Val31Ile | missense_variant | Exon 4 of 7 | XP_047289566.1 | ||
MPZL1 | NM_001146191.2 | c.258+6730G>A | intron_variant | Intron 2 of 2 | NP_001139663.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249194Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134590
GnomAD4 exome AF: 0.00000960 AC: 14AN: 1458390Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 725550
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.463G>A (p.V155I) alteration is located in exon 3 (coding exon 3) of the MPZL1 gene. This alteration results from a G to A substitution at nucleotide position 463, causing the valine (V) at amino acid position 155 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at